CMIC Group

Activities: Manufacturing

Trending Articles

  1. GSK bolsters its US drug manufacturing capabilities with $800m investment The expansion will double the size and capacity of its Marietta site, supporting the manufacture of sterile liquid vaccines and production for clinical trials
  2. AbbVie to bolster its neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition The acquisition will add to AbbVie's Alzheimer's drug pipeline, while also allowing it access to Aliada's proprietary blood-brain barrier-crossing technology
  3. The art of the antibody curator Catherine Bladen, PhD, Chief Operating Officer at Vector Laboratories, explains how customisable and consistent antibodies fuel better research and drug development
  4. Eli Lilly to leverage ViaNautis Bio's nanovesicle technology for genetic medicine development ViaNautis' polyNaut nanovesicles can deliver genetic materials to specific tissues or cell types, allowing for more accurate therapeutic targeting
  5. Integra pipettes drive progress in RAPT Therapeutics’ small molecule inhibitor development Accelerating R&D for cancer and inflammatory disease treatment

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

CMIC Group establishes biopharma CDMO in Japan

Single-use facility in Shizuoka, Japan has been established to provide process development and GMP manufacturing of antibody drugs using mammalian cell line
Subscribe now